Better Buy: Eli Lilly or Novo Nordisk?

Group 1 - Novo Nordisk's stock experienced a significant decline of 17% following the announcement of disappointing trial results [1] - The video discusses whether the current dip in Novo Nordisk's stock presents a buying opportunity compared to Eli Lilly [1] Group 2 - Stock prices referenced were from the trading day of December 20, 2024, with the video published on December 22, 2024 [2]